메뉴 건너뛰기




Volumn 8, Issue 5, 2013, Pages 675-680

Evaluation of fosfomycin activity against uropathogens in a fosfomycin-naive population in South India: A prospective study

Author keywords

activity; Enterococcus; Escherichia coli; fosfomycin; in vitro; susceptibility; urinary tract infection; urine

Indexed keywords

EXTENDED SPECTRUM BETA LACTAMASE; FOSFOMYCIN;

EID: 84877259388     PISSN: 17460913     EISSN: 17460921     Source Type: Journal    
DOI: 10.2217/fmb.13.31     Document Type: Article
Times cited : (31)

References (21)
  • 2
    • 83655201293 scopus 로고    scopus 로고
    • Fosfomycin: An old-new antibiotic
    • Raz R. Fosfomycin: an old-new antibiotic. Clin. Microbiol. Infect. 18(1), 4-7 (2012).
    • (2012) Clin. Microbiol. Infect. , vol.18 , Issue.1 , pp. 4-7
    • Raz, R.1
  • 3
    • 77955646149 scopus 로고    scopus 로고
    • Fosfomycin versus other antibiotics for the treatment of cystitis: A meta-analysis of randomized controlled trials
    • Falagas ME, Vouloumanou EK, Togias AG et al. Fosfomycin versus other antibiotics for the treatment of cystitis: a meta-analysis of randomized controlled trials. J. Antimicrob. Chemother. 65(9), 1862-1877 (2010).
    • (2010) J. Antimicrob. Chemother. , vol.65 , Issue.9 , pp. 1862-1877
    • Falagas, M.E.1    Vouloumanou, E.K.2    Togias, A.G.3
  • 4
    • 0031003980 scopus 로고    scopus 로고
    • Fosfomycin tromethamine A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy as a single-dose oral treatment for acute uncomplicated lower urinary tract infections
    • Patel SS, Balfour JA, Bryson HM. Fosfomycin tromethamine. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy as a single-dose oral treatment for acute uncomplicated lower urinary tract infections. Drugs 53(4), 637-656 (1997).
    • (1997) Drugs , vol.53 , Issue.4 , pp. 637-656
    • Patel, S.S.1    Balfour, J.A.2    Bryson, H.M.3
  • 5
    • 0037299149 scopus 로고    scopus 로고
    • Epidemiology of urinary tract infections: Incidence, morbidity, and economic costs
    • Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Dis. Mon. 49(2), 53-70 (2003).
    • (2003) Dis. Mon. , vol.49 , Issue.2 , pp. 53-70
    • Foxman, B.1
  • 7
    • 34548419669 scopus 로고    scopus 로고
    • Old antibiotics for infections in critically ill patients
    • Falagas ME, Kopterides P. Old antibiotics for infections in critically ill patients. Curr. Opin. Crit. Care 13(5), 592-597 (2007).
    • (2007) Curr. Opin. Crit. Care , vol.13 , Issue.5 , pp. 592-597
    • Falagas, M.E.1    Kopterides, P.2
  • 8
    • 72149117149 scopus 로고    scopus 로고
    • Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum beta-lactamase producing, Enterobacteriaceae infections: A systematic review
    • Falagas ME, Kastoris AC, Kapaskelis AM, Karageorgopoulos DE. Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum beta-lactamase producing, Enterobacteriaceae infections: a systematic review. Lancet Infect. Dis. 10(1), 43-50 (2010).
    • (2010) Lancet Infect. Dis. , vol.10 , Issue.1 , pp. 43-50
    • Falagas, M.E.1    Kastoris, A.C.2    Kapaskelis, A.M.3    Karageorgopoulos, D.E.4
  • 9
    • 77958193834 scopus 로고    scopus 로고
    • Treatment of resistant enterococcal urinary tract infections
    • Swaminathan S, Alangaden GJ. Treatment of resistant enterococcal urinary tract infections. Curr. Infect. Dis. Rep. 12(6), 455-464 (2010).
    • (2010) Curr. Infect. Dis. Rep. , vol.12 , Issue.6 , pp. 455-464
    • Swaminathan, S.1    Alangaden, G.J.2
  • 12
    • 84857646835 scopus 로고    scopus 로고
    • Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: An international expert proposal for interim standard definitions for acquired resistance
    • Magiorakos AP, Srinivasan A, Carey RB et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin. Microbiol. Infect. 18(3), 268-281 (2012).
    • (2012) Clin. Microbiol. Infect. , vol.18 , Issue.3 , pp. 268-281
    • Magiorakos, A.P.1    Srinivasan, A.2    Carey, R.B.3
  • 13
    • 68549083465 scopus 로고    scopus 로고
    • In vitro activity of fosfomycin against ESBL-producing enterobacteria of urinary origin
    • Hernandez MS, Garcia JA, Munoz JL. In vitro activity of fosfomycin against ESBL-producing enterobacteria of urinary origin. Rev. Esp. Quimioter. 22(1), 25-29 (2009).
    • (2009) Rev. Esp. Quimioter. , vol.22 , Issue.1 , pp. 25-29
    • Hernandez, M.S.1    Garcia, J.A.2    Munoz, J.L.3
  • 15
    • 0141646506 scopus 로고    scopus 로고
    • In vitro activity of fosfomycin against Gram-negative urinary pathogens and the biological cost of fosfomycin resistance
    • Marchese A, Gualco L, Debbia EA, Schito GC, Schito AM. In vitro activity of fosfomycin against Gram-negative urinary pathogens and the biological cost of fosfomycin resistance. Int. J. Antimicrob. Agents 22(Suppl. 2), 53-59 (2003).
    • (2003) Int. J. Antimicrob. Agents , vol.22 , Issue.SUPPL. 2 , pp. 53-59
    • Marchese, A.1    Gualco, L.2    Debbia, E.A.3    Schito, G.C.4    Schito, A.M.5
  • 16
    • 67650462781 scopus 로고    scopus 로고
    • Fosfomycin for the treatment of infections caused by Gram-positive cocci with advanced antimicrobial drug resistance: A review of microbiological, animal and clinical studies
    • Falagas ME, Roussos N, Gkegkes ID, Rafailidis PI, Karageorgopoulos DE. Fosfomycin for the treatment of infections caused by Gram-positive cocci with advanced antimicrobial drug resistance: a review of microbiological, animal and clinical studies. Expert Opin. Investig. Drugs 18(7), 921-944 (2009).
    • (2009) Expert Opin. Investig. Drugs , vol.18 , Issue.7 , pp. 921-944
    • Falagas, M.E.1    Roussos, N.2    Gkegkes, I.D.3    Rafailidis, P.I.4    Karageorgopoulos, D.E.5
  • 17
    • 0028097111 scopus 로고
    • Fosfomycin trometamol and the single-dose treatment of cystitis
    • Greenwood D. Fosfomycin trometamol and the single-dose treatment of cystitis. J. Med. Microbiol. 41(5), 293-294 (1994).
    • (1994) J. Med. Microbiol. , vol.41 , Issue.5 , pp. 293-294
    • Greenwood, D.1
  • 18
    • 0023133785 scopus 로고
    • Activity of Monuril in lower urinary tract infections due to fosfomycin-resistant bacteria
    • Neuman M, Rufin F. Activity of Monuril in lower urinary tract infections due to fosfomycin-resistant bacteria. Eur. Urol. 13(Suppl. 1), 105-107 (1987).
    • (1987) Eur. Urol. , vol.13 , Issue.SUPPL. 1 , pp. 105-107
    • Neuman, M.1    Rufin, F.2
  • 20
    • 84862936625 scopus 로고    scopus 로고
    • Fosfomycin: Evaluation of the published evidence on the emergence of antimicrobial resistance in Gram-negative pathogens
    • Karageorgopoulos DE, Wang R, Yu XH, Falagas ME. Fosfomycin: evaluation of the published evidence on the emergence of antimicrobial resistance in Gram-negative pathogens. J. Antimicrob. Chemother. 67(2), 255-268 (2012).
    • (2012) J. Antimicrob. Chemother. , vol.67 , Issue.2 , pp. 255-268
    • Karageorgopoulos, D.E.1    Wang, R.2    Yu, X.H.3    Falagas, M.E.4
  • 21
    • 3843049140 scopus 로고    scopus 로고
    • Inappropriate medication use in older adults: Does nitrofurantoin belong on the list for the reasons stated? Arch
    • Kunin CM. Inappropriate medication use in older adults: does nitrofurantoin belong on the list for the reasons stated? Arch. Intern. Med. 164(15), 1701 (2004).
    • (2004) Intern. Med. , vol.164 , Issue.15 , pp. 1701
    • Kunin, C.M.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.